Ingersoll Rand Inc. announced on August 4, 2025, the acquisition of Dave Barry Plastics, further expanding its life sciences portfolio. This strategic investment aims to enhance the company's offerings in high-growth healthcare technology industries.
Ireland-based Dave Barry Plastics specializes in designing and manufacturing plastic product solutions for the life science and healthcare technology sectors. These products are specifically utilized in clean rooms to minimize contamination risks during manufacturing, packaging, and storage processes.
Dave Barry Plastics will integrate into the Life Sciences platform within Ingersoll Rand's Precision and Science Technologies (P&ST) segment. This acquisition reflects Ingersoll Rand's commitment to expanding its portfolio with innovative, high-performance solutions and driving growth through purposeful, direct investments.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.